Leila B. Giron

1.9k total citations
39 papers, 644 citations indexed

About

Leila B. Giron is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Leila B. Giron has authored 39 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Virology, 19 papers in Infectious Diseases and 15 papers in Immunology. Recurrent topics in Leila B. Giron's work include HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS drug development and treatment (9 papers). Leila B. Giron is often cited by papers focused on HIV Research and Treatment (22 papers), Immune Cell Function and Interaction (12 papers) and HIV/AIDS drug development and treatment (9 papers). Leila B. Giron collaborates with scholars based in United States, Brazil and Japan. Leila B. Giron's co-authors include Mohamed Abdel‐Mohsen, Alan Landay, Qin Liu, Andrew V. Kossenkov, Ali Keshavarzian, Mohammad Damra, Xiangfan Yin, Luis J. Montaner, Emmanouil Papasavvas and Florent Colomb and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Leila B. Giron

39 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leila B. Giron United States 16 283 243 190 148 98 39 644
Jesper Falkesgaard Højen Denmark 13 348 1.2× 167 0.7× 231 1.2× 236 1.6× 85 0.9× 17 663
Xiangfan Yin United States 15 215 0.8× 318 1.3× 182 1.0× 143 1.0× 136 1.4× 29 797
Sijia He China 12 398 1.4× 101 0.4× 131 0.7× 108 0.7× 89 0.9× 37 773
Jingna Xun China 13 484 1.7× 168 0.7× 82 0.4× 71 0.5× 108 1.1× 33 738
Sima S. Toussi United States 14 342 1.2× 121 0.5× 135 0.7× 99 0.7× 213 2.2× 26 776
Silvia Scabini Italy 11 233 0.8× 159 0.7× 136 0.7× 45 0.3× 122 1.2× 33 776
Katharina Hartmann Germany 15 174 0.6× 155 0.6× 145 0.8× 84 0.6× 210 2.1× 50 821
Madison Schank United States 18 162 0.6× 245 1.0× 236 1.2× 155 1.0× 174 1.8× 30 714
Lorna Leal Spain 16 365 1.3× 203 0.8× 152 0.8× 273 1.8× 112 1.1× 42 648
Tendai Mugwagwa United Kingdom 11 143 0.5× 113 0.5× 432 2.3× 45 0.3× 182 1.9× 30 780

Countries citing papers authored by Leila B. Giron

Since Specialization
Citations

This map shows the geographic impact of Leila B. Giron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leila B. Giron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leila B. Giron more than expected).

Fields of papers citing papers by Leila B. Giron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leila B. Giron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leila B. Giron. The network helps show where Leila B. Giron may publish in the future.

Co-authorship network of co-authors of Leila B. Giron

This figure shows the co-authorship network connecting the top 25 collaborators of Leila B. Giron. A scholar is included among the top collaborators of Leila B. Giron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leila B. Giron. Leila B. Giron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giron, Leila B., Alexander Pasternak, & Mohamed Abdel‐Mohsen. (2024). Soluble markers of viral rebound and post-treatment HIV control. Current Opinion in HIV and AIDS. 20(1). 61–69. 2 indexed citations
2.
Adeniji, Opeyemi S., Devivasha Bordoloi, Jeff Martinson, et al.. (2023). Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. mBio. 14(1). e0339322–e0339322. 9 indexed citations
3.
Giron, Leila B., Toshiro Niki, Thomas A. Premeaux, et al.. (2022). Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice. AIDS. 37(4). 571–577. 5 indexed citations
4.
Ma, Tongcui, Matthew McGregor, Leila B. Giron, et al.. (2022). Single-cell glycomics analysis by CyTOF-Lec reveals glycan features defining cells differentially susceptible to HIV. eLife. 11. 18 indexed citations
5.
Giron, Leila B., Michelle L. D’Antoni, Cecilia M. Shikuma, et al.. (2022). Circulating brain-derived extracellular vesicles expressing neuroinflammatory markers are associated with HIV-related neurocognitive impairment. Frontiers in Immunology. 13. 1033712–1033712. 15 indexed citations
6.
Giron, Leila B., Clovis S. Palmer, Qin Liu, et al.. (2021). Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. Nature Communications. 12(1). 3922–3922. 37 indexed citations
7.
Giron, Leila B., Emmanouil Papasavvas, Xiangfan Yin, et al.. (2021). Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption. mBio. 12(1). 20 indexed citations
8.
Adeniji, Opeyemi S., Leila B. Giron, Mansi Purwar, et al.. (2021). COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions. mBio. 12(2). 45 indexed citations
9.
Choi, Hyeree, Opeyemi S. Adeniji, Leila B. Giron, et al.. (2021). Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity. Frontiers in Oncology. 11. 778989–778989. 29 indexed citations
10.
Giron, Leila B., Harsh Dweep, Xiangfan Yin, et al.. (2020). Severe COVID-19 is fueled by disrupted gut barrier integrity. 29(1). 29–30. 7 indexed citations
11.
Colomb, Florent, Leila B. Giron, Leticia Kuri-Cervantes, et al.. (2020). Sialyl-LewisX Glycoantigen Is Enriched on Cells with Persistent HIV Transcription during Therapy. Cell Reports. 32(5). 107991–107991. 15 indexed citations
12.
Giron, Leila B., Florent Colomb, Emmanouil Papasavvas, et al.. (2020). Interferon-α alters host glycosylation machinery during treated HIV infection. EBioMedicine. 59. 102945–102945. 11 indexed citations
13.
Hunter, James, Leila B. Giron, Maria Cecília Araripe Sucupira, et al.. (2020). HCV genotype profile in Brazil of mono-infected and HIV co-infected individuals: A survey representative of an entire country. PLoS ONE. 15(1). e0227082–e0227082. 8 indexed citations
14.
Routhu, Nanda Kishore, Sylvain Lehoux, Leila B. Giron, et al.. (2019). Glycosylation of Zika Virus is Important in Host–Virus Interaction and Pathogenic Potential. International Journal of Molecular Sciences. 20(20). 5206–5206. 36 indexed citations
15.
Diaz, Ricardo Sobhie, Iart Luca Shytaj, Leila B. Giron, et al.. (2019). Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial. International Journal of Antimicrobial Agents. 54(5). 592–600. 29 indexed citations
16.
Giron, Leila B., et al.. (2019). Laboratory surrogate markers of residual HIV replication among distinct groups of individuals under antiretroviral therapy. PLoS ONE. 14(6). e0217502–e0217502. 3 indexed citations
17.
Colomb, Florent, Leila B. Giron, Irena Trbojević‐Akmačić, Gordan Lauc, & Mohamed Abdel‐Mohsen. (2019). Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis. Current HIV/AIDS Reports. 16(2). 151–168. 21 indexed citations
18.
Giron, Leila B., et al.. (2015). High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil. The Brazilian Journal of Infectious Diseases. 19(6). 631–635. 13 indexed citations
19.
López, Luis Fernández, Marcelo Nascimento Burattini, Juliana Terzi Maricato, et al.. (2014). In Vivo HIV-1 Hypermutation and Viral Loads Among Antiretroviral-Naive Brazilian Patients. AIDS Research and Human Retroviruses. 30(9). 867–880. 6 indexed citations
20.
Giron, Leila B., Suzane Ramos da Silva, Alexandre Naime Barbosa, et al.. (2013). Impact of Epstein–Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF‐1 gene in patients harboring the human immunodeficiency virus. Journal of Medical Virology. 85(12). 2110–2118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesper Falkesgaard Højen Breakdown of academic impact, for papers by Xiangfan Yin Breakdown of academic impact, for papers by Sijia He Breakdown of academic impact, for papers by Jingna Xun Breakdown of academic impact, for papers by Sima S. Toussi Breakdown of academic impact, for papers by Silvia Scabini Breakdown of academic impact, for papers by Katharina Hartmann Breakdown of academic impact, for papers by Madison Schank Breakdown of academic impact, for papers by Lorna Leal Breakdown of academic impact, for papers by Tendai Mugwagwa
Rankless by CCL
2026